Evidence map›Paper›PMID 41654652›Full record

ArticleMolecular psychiatry2026

Circulating mitochondrial and cellular damage markers in long COVID: Links to cognitive function, psychological distress, and inflammation.

Lynn Matits, Jana Schellenberg, Matthias Mack, Iris-Tatjana Kolassa, Claudia Schilling, Dietrich Rothenbacher, Raphael S Peter, Winfried V Kern, Alexandra Nieters, Jürgen M Steinacker and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lynn MatitsSports and Rehabilitation Medicine, Ulm University Hospital, Ulm, Germany. lynn.matits@uni-ulm.de.ORCID http://orcid.org/0000-0002-4777-7066
Jana SchellenbergSports and Rehabilitation Medicine, Ulm University Hospital, Ulm, Germany.ORCID http://orcid.org/0000-0002-7467-2614
Matthias MackClinical & Biological Psychology, Institute of Psychology and Education, Ulm University, Ulm, Germany.ORCID http://orcid.org/0000-0001-7937-079X
Iris-Tatjana KolassaClinical & Biological Psychology, Institute of Psychology and Education, Ulm University, Ulm, Germany.ORCID http://orcid.org/0000-0001-7847-1847
Claudia SchillingGerman Center for Mental Health (DZPG), Mannheim-Heidelberg-Ulm, Germany.ORCID http://orcid.org/0000-0001-7631-1452
Dietrich RothenbacherGerman Center for Child and Adolescent Health (DZKJ), partner site Ulm, Ulm, Germany.
Raphael S PeterInstitute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
Winfried V KernDivision of Infectious Diseases, Department of Medicine II, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.
Alexandra NietersInstitute for Immunodeficiency, Medical Centre and Faculty of Medicine, Albert-Ludwigs-University, Freiburg, Germany.
Jürgen M SteinackerGerman Center for Child and Adolescent Health (DZKJ), partner site Ulm, Ulm, Germany.
Daniel A BizjakSports and Rehabilitation Medicine, Ulm University Hospital, Ulm, Germany.ORCID http://orcid.org/0000-0003-4075-0204
EPILOC Phase 2 Study Group

Funding

Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (Ministry of Science, Research and Art Baden-Württemberg) MR/S028188/1
6 · The paper itself

Abstract

Persistent mitochondrial inflexibility and mitochondrial damage may contribute to Post-Acute Sequelae of COVID-19 (PASC). However, data linking mitochondrial biomarkers, such as circulating cell-free mitochondrial DNA (ccf-mtDNA) to long-COVID symptoms remain limited. We analyzed ccf-mtDNA relative to glycerinaldehyd-3-phosphat-dehydrogenase and total cell-free DNA (ccf-DNA) in a nested case-control study of 228 adults (PASC: n = 128, recovered controls: n = 100). Possible associations between these markers and general cognition, verbal memory, psychological distress, and inflammation were also examined. ccf-DNA (measured via UV-Vis spectroscopy), relative ccf-mtDNA (measured via quantitative real-time PCR, -ΔCT), C-reactive protein [CRP], and systemic immune-inflammation index [SII] were assessed. Principal component analysis (PCA) was applied to (neuro)psychological tests to derive three components: general cognition, verbal memory, and psychological distress, which were used in further analyses. PASC patients exhibited significantly lower cognitive function and higher psychological distress than recovered controls. They also had elevated CRP levels and lower relative ccf-mtDNA, with 25% showing low-grade inflammation. Across all participants, general cognition correlated positively with the relative ccf-mtDNA, while CRP correlated negatively with the relative ccf-mtDNA. Mediation analysis suggested relative ccf-mtDNA as a potential mediator of CRP differences between PASC and recovered controls. However, CRP differences did not remain after controlling for potential confounders (age, sex, education, smoking, body mass index, psychiatric medication). Lower relative ccf-mtDNA in PASC might indicate altered mitochondrial quality control, potentially leading to mitochondrial dysfunction, accumulation of damaged mitochondria, and increased inflammation.

Indexed as

DNA, MitochondrialInflammationPost-Acute COVID-19 SyndromeAdultAgedBiomarkersCase-Control StudiesCognitionC-Reactive ProteinFemaleHumansMaleMiddle AgedMitochondriaNeuropsychological TestsPsychological DistressBiomarkersC-Reactive ProteinDNA, Mitochondrial

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.